HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bo Nordenskjöld Selected Research

Tamoxifen

5/2022PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients.
1/2022Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature.
1/2021MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit.
1/2021Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy: A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial.
12/2020Tumour-infiltrating lymphocytes as a prognostic and tamoxifen predictive marker in premenopausal breast cancer: data from a randomised trial with long-term follow-up.
5/2020Low RAB6C expression is a predictor of tamoxifen benefit in estrogen receptor-positive/progesterone receptor-negative breast cancer.
9/2019Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer.
2/2018Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.
1/2018Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer.
11/2017Tamoxifen therapy benefit for patients with 70-gene signature high and low risk.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bo Nordenskjöld Research Topics

Disease

63Breast Neoplasms (Breast Cancer)
05/2022 - 01/2003
40Neoplasms (Cancer)
01/2022 - 01/2002
3Triple Negative Breast Neoplasms
12/2020 - 02/2016
3Neoplasm Metastasis (Metastasis)
11/2017 - 01/2008
2Second Primary Neoplasms (Neoplasms, Second)
04/2017 - 01/2008
2Coronary Disease (Coronary Heart Disease)
04/2013 - 11/2005
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2017
1Lung Neoplasms (Lung Cancer)
04/2017
1Heart Diseases (Heart Disease)
04/2013
1Obesity
01/2010
1Margins of Excision
01/2008
1Ataxia Telangiectasia (Louis Bar Syndrome)
05/2007
1Hypoxia (Hypoxemia)
05/2006
1Carcinogenesis
05/2005

Drug/Important Bio-Agent (IBA)

47TamoxifenFDA LinkGeneric
05/2022 - 01/2003
21Estrogen ReceptorsIBA
01/2022 - 01/2003
17Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2005
9Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 07/2005
7Hormones (Hormone)IBA
05/2022 - 07/2005
7Biomarkers (Surrogate Marker)IBA
05/2021 - 01/2008
6Phenobarbital (Luminal)FDA Link
05/2022 - 08/2015
5EnzymesIBA
03/2010 - 01/2005
4Estrogens (Estrogen)FDA Link
05/2009 - 01/2003
3Phosphotransferases (Kinase)IBA
07/2019 - 01/2003
3Docetaxel (Taxotere)FDA Link
08/2015 - 01/2008
33 (or 17)-beta-hydroxysteroid dehydrogenaseIBA
03/2010 - 08/2006
2Biological FactorsIBA
09/2019 - 01/2018
2ParaffinIBA
11/2017 - 04/2013
2Oxidoreductases (Dehydrogenase)IBA
01/2012 - 03/2010
2Pharmaceutical PreparationsIBA
03/2010 - 08/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2010 - 01/2008
2Fluorouracil (Carac)FDA LinkGeneric
02/2009 - 01/2008
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2009 - 01/2008
2Messenger RNA (mRNA)IBA
11/2008 - 03/2008
2Aromatase (CYP19)IBA
11/2008 - 08/2006
2human ERBB2 proteinIBA
05/2008 - 07/2005
2Cyclin D1IBA
06/2007 - 05/2005
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
01/2007 - 01/2005
2SteroidsIBA
08/2006 - 08/2006
1Homeodomain Proteins (Proteins, Homeobox)IBA
01/2022
1Histones (Histone)IBA
01/2022
1Aurora Kinase AIBA
01/2022
1Epidermal Growth Factor (EGF)IBA
01/2022
1inositol hexakisphosphate kinaseIBA
05/2021
1Letrozole (Femara)FDA LinkGeneric
01/2021
1Minichromosome Maintenance ProteinsIBA
01/2021
1ErbB Receptors (EGF Receptor)IBA
12/2020
1Small Interfering RNA (siRNA)IBA
07/2019
1Protein Tyrosine PhosphatasesIBA
07/2019
1Tyrosine (L-Tyrosine)FDA Link
07/2019
1Regulatory-Associated Protein of mTORIBA
02/2018
1Formaldehyde (Formol)FDA Link
11/2017
1ERRalpha Estrogen-Related ReceptorIBA
03/2016
1Androgen Receptors (Androgen Receptor)IBA
02/2016
1AnthracyclinesIBA
08/2015
1Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA
08/2015
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
06/2015
1TOR Serine-Threonine KinasesIBA
06/2015
1GTP-Binding Proteins (G-Protein)IBA
05/2014
1LigandsIBA
05/2014
1WW Domain-Containing OxidoreductaseIBA
04/2013
1Protein Isoforms (Isoforms)IBA
04/2013
1DNA (Deoxyribonucleic Acid)IBA
04/2011
1Serine (L-Serine)FDA Link
03/2010
1Estrogen Receptor alphaIBA
03/2010
1p21-Activated KinasesIBA
03/2010
1Indicators and Reagents (Reagents)IBA
01/2010
1Cyclin EIBA
02/2009
1Retinoblastoma ProteinIBA
02/2009
1SulfatasesIBA
11/2008
1Methotrexate (Mexate)FDA LinkGeneric
01/2008
1OligonucleotidesIBA
01/2008
1Pamidronate (Aredia)FDA LinkGeneric
01/2008
1Checkpoint Kinase 1IBA
01/2008
1Diphosphonates (Bisphosphonates)IBA
01/2008
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
06/2007
1Cytochrome P-450 CYP3AIBA
01/2007
1Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA
01/2007
1Dinoprostone (PGE2)FDA Link
08/2006
1Estradiol (Delestrogen)FDA LinkGeneric
08/2006
1EstroneFDA Link
08/2006
1Codon (Codons)IBA
05/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2005
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2005
1P-2 (P 2)IBA
07/2005

Therapy/Procedure

24Therapeutics
01/2021 - 01/2003
10Radiotherapy
01/2018 - 01/2002
4Adjuvant Chemotherapy
08/2015 - 05/2007
3Drug Therapy (Chemotherapy)
02/2009 - 05/2005
2Mastectomy (Mammectomy)
01/2018 - 11/2017
2Aftercare (After-Treatment)
04/2017 - 04/2013
1Segmental Mastectomy (Lumpectomy)
11/2017